GB2108489B - Pharmaceutical composition comprising piperidine derivatives - Google Patents

Pharmaceutical composition comprising piperidine derivatives

Info

Publication number
GB2108489B
GB2108489B GB08220042A GB8220042A GB2108489B GB 2108489 B GB2108489 B GB 2108489B GB 08220042 A GB08220042 A GB 08220042A GB 8220042 A GB8220042 A GB 8220042A GB 2108489 B GB2108489 B GB 2108489B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
piperidine derivatives
piperidine
derivatives
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08220042A
Other versions
GB2108489A (en
Inventor
John Leheup Archibald
Terence James Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Priority to GB08220042A priority Critical patent/GB2108489B/en
Publication of GB2108489A publication Critical patent/GB2108489A/en
Application granted granted Critical
Publication of GB2108489B publication Critical patent/GB2108489B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
GB08220042A 1980-03-01 1982-07-09 Pharmaceutical composition comprising piperidine derivatives Expired GB2108489B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08220042A GB2108489B (en) 1980-03-01 1982-07-09 Pharmaceutical composition comprising piperidine derivatives

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8007048 1980-03-01
GB8027435 1980-08-22
GB08220042A GB2108489B (en) 1980-03-01 1982-07-09 Pharmaceutical composition comprising piperidine derivatives

Publications (2)

Publication Number Publication Date
GB2108489A GB2108489A (en) 1983-05-18
GB2108489B true GB2108489B (en) 1984-06-06

Family

ID=27260880

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08220042A Expired GB2108489B (en) 1980-03-01 1982-07-09 Pharmaceutical composition comprising piperidine derivatives

Country Status (1)

Country Link
GB (1) GB2108489B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528235D0 (en) * 1985-11-15 1985-12-18 Wyeth John & Brother Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
GB2108489A (en) 1983-05-18

Similar Documents

Publication Publication Date Title
ZA813465B (en) Pharmaceutical composition
IL62200A (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
CY1574A (en) Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives
GB8303552D0 (en) Piperidine derivatives
DE3376069D1 (en) Piperidine derivatives
ZA81136B (en) Pharmaceutical compositions
ZA816766B (en) Anti-ischaemic pharmaceutical compositions
NZ198862A (en) Enkephalin derivatives and pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
DE2963225D1 (en) Novel piperidine derivatives and pharmaceutical compositions containing them
GB2044254B (en) Piperidine derivatives
NZ205716A (en) Piperidine derivatives and pharmaceutical compositions
PH16754A (en) Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
PT73952B (en) Pharmaceutical compositions
ZA815356B (en) Injectable pharmaceutical compositions
GB2106108B (en) Piperidine derivatives
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
GB2108489B (en) Pharmaceutical composition comprising piperidine derivatives
ZA81919B (en) Pharmaceutical compositions containing a naphyridine derivative
ZA817373B (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
ZA815175B (en) Pharmaceutical composition
NZ196464A (en) Steroid-spiro-oxathiazolidine derivatives and pharmaceutical compositions
JPS55108816A (en) Pharmaceutical composition containing benzimidazolee2 derivative

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20010225